📰 Boundless Bio News
Page 3 - Boundless Bio News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Boundless Bio. Real-time updates on events, politics, business and more.
June 24, 2022
The research campus directly opposite San Diego's famed Torrey Pines Golf Course will be overhauled to match — and potentially even elevate — the life science prestige of its address at the corner of Science Park Road and North Torrey Pines Road.
January 17, 2022
Boundless Bio Appoints Peter Krein, Ph.D., as Vice President, Precision Medicine - read this article along with other careers information, tips and advice on BioSpace
November 3, 2021
/PRNewswire/ -- Epic Sciences, Inc, developer of novel diagnostics to personalize and advance the treatment and management of cancer, today announced the...
November 3, 2021
/PRNewswire/ -- Epic Sciences, Inc, developer of novel diagnostics to personalize and advance the treatment and management of cancer, today announced the...
April 29, 2021
Get the latest industry news first when you subscribe to our daily newsletter. We will never sell or share your information without your consent. See our privacy policy.
April 16, 2021
GT Apeiron Therapeutics Strengthens Advisory Board News provided by Share this article Share this article SHANGHAI, April 15, 2021 /PRNewswire/ -- Keith Lenden and Dr. Honggang Bi has been appointed as new members of the Advisory Board at GT Apeiron Therapeutics, an AI empowered drug discovery start-up developing oncology therapeutics. Mr. Lenden and Dr. Bi add further expertise in drug discovery innovation, translational medicine, and clinical development; and deep knowledge and perspectives ...
December 22, 2020
This story is available exclusively to Insider subscribers. Become an Insider and start reading now. Healthcare startups that had a breakout year in 2020 are poised to have an even better 2021, investors told Business Insider. Startups, especially those focused on virtual care benefitted from being in the right place at the right time amid the global pandemic. Business Insider interviewed dozens of venture capitalists and other private investors to learn whic...